HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hela l-CaD is implicated in the migration of endothelial cells/endothelial progenitor cells in human neoplasms.

Abstract
Caldesmon (CaD) is a major actin-binding protein distributed in a variety of cell types. No functional differences among the isoforms in in vitro studies were found so far. In a previous study we found that the low molecular caldesmon isoform (Hela l-CaD) is expressed in endothelial cells (ECs)/endothelial progenitor cells (EPCs) in tumor vasculature of various human tumors. Activation of cell motility is necessary for the navigation of the tip ECs during angiogenesis, and migration of EPCs from the bone marrow during vasculogenesis. In the present study we searched for features of motility and the intracellular expression sites of Hela l-CaD in ECs/EPCs of various human tumors under histologically preserved microenviroment. We discovered a variety of motility-related cell protrusions like filopodia, microspikes, lamellipodia, podosomes, membrane blebs and membrane ruffles in the activated ECs/EPCs. Hela l-CaD appeared to be invariably expressed in the subregions of these cell protrusions. The findings suggest that Hela l-CaD is implicated in the migration of ECs/EPC in human neoplasms where they contribute to tumor vasculogenesis and angiogenesis.
AuthorsPing-Pin Zheng, Marcel van der Weiden, Johan M Kros
JournalCell adhesion & migration (Cell Adh Migr) 2007 Apr-Jun Vol. 1 Issue 2 Pg. 84-91 ISSN: 1933-6926 [Electronic] United States
PMID19329885 (Publication Type: Journal Article)
Chemical References
  • Calmodulin-Binding Proteins
  • Gelsolin
Topics
  • Calmodulin-Binding Proteins (genetics, metabolism)
  • Cell Membrane (metabolism)
  • Cell Movement
  • Endothelial Cells (cytology)
  • Gelsolin (metabolism)
  • HeLa Cells
  • Humans
  • Neoplasms (blood supply, genetics, metabolism, pathology)
  • Neovascularization, Pathologic
  • Stem Cells (cytology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: